NextFin

ARKK Boosts CRSP by $8.7M While Offloading SHOP and COIN with $29M in Losses

Summarized by NextFin AI
  • On February 26, 2026, ARKK adjusted its positions, reflecting a tactical reallocation in its portfolio focused on innovative technology and biotech sectors.
  • CRISPR Therapeutics AG (CRSP) saw an increase in portfolio weight by 20%, indicating confidence in biotech innovation.
  • Significant sell-offs occurred in Shopify Inc-A (SHOP) and Roku Inc-A (ROKU), suggesting a shift away from certain tech growth stocks.
  • Tesla Inc (TSLA) experienced a modest reduction in holdings, possibly for profit-taking or risk management purposes.

ARKK Daily Position Changes Report for 2026-02-26

Summary of Position Changes:

  • BEAM (Beam Therapeutics Inc): Buy with estimated trade value change of $9,253,285.68, portfolio weight change of 18.7000%.
  • BLSH: Sell with estimated trade value change of -$3,358,978.20, portfolio weight change of -3.5000%.
  • COIN (Coinbase Global Inc-A): Sell with estimated trade value change of -$13,026,911.15, portfolio weight change of -18.0000%.
  • CRSP (CRISPR Therapeutics AG): Buy with estimated trade value change of $8,720,708.00, portfolio weight change of 20.0000%.
  • PLTR: Sell with estimated trade value change of -$4,171,040.24, portfolio weight change of -4.1000%.
  • ROKU (Roku Inc-A): Sell with estimated trade value change of -$11,346,034.20, portfolio weight change of -14.6000%.
  • SHOP (Shopify Inc-A): Sell with estimated trade value change of -$16,865,733.32, portfolio weight change of -23.7000%.
  • TEM (Tempus AI Inc-A): Sell with estimated trade value change of -$2,032,179.30, portfolio weight change of 1.7000%.
  • TSLA (Tesla Inc): Sell with estimated trade value change of -$11,042,396.20, portfolio weight change of -8.6000%.
  • TWST (Twist Bioscience Corp): Buy with estimated trade value change of $433,274.10, portfolio weight change of 3.3000%.

Analysis and Interpretation:

On 2026-02-26, ARKK adjusted its positions across several key holdings reflecting a tactical reallocation within its portfolio focused on innovative technology and biotech sectors. Tesla Inc (TSLA) saw a modest reduction, indicative of potential profit-taking or risk management. CRISPR Therapeutics AG (CRSP) increased, signaling continued confidence in biotech innovation. Sell-offs in Shopify Inc-A (SHOP) and Roku Inc-A (ROKU) suggest a rotational shift away from certain tech growth stocks. Overall, these changes align with ARKK's dynamic and active portfolio management style, balancing exposure to emerging disruptive technologies with risk control.

Position Changes Table:

Ticker Company Name Direction Shares Traded (estimated) Estimated Trade Value ($) % of Portfolio Change
BEAM Beam Therapeutics Inc Buy 9,253,285.68 0.187
BLSH Sell -3,358,978.20 -0.035
COIN Coinbase Global Inc-A Sell -13,026,911.15 -0.180
CRSP CRISPR Therapeutics AG Buy 8,720,708.00 0.200
PLTR Sell -4,171,040.24 -0.041
ROKU Roku Inc-A Sell -11,346,034.20 -0.146
SHOP Shopify Inc-A Sell -16,865,733.32 -0.237
TEM Tempus AI Inc-A Sell -2,032,179.30 0.017
TSLA Tesla Inc Sell -11,042,396.20 -0.086
TWST Twist Bioscience Corp Buy 433,274.10 0.033

Explore more exclusive insights at nextfin.ai.

Insights

What are the key principles behind ARK's investment strategy?

How has ARKK's portfolio changed over recent years?

What sectors are currently favored by ARKK according to recent trades?

What recent trades indicate ARKK's confidence in biotech innovations?

What market trends are influencing ARK's position adjustments?

What was the rationale behind selling Shopify and Roku stocks?

How do ARKK's position changes reflect its risk management approach?

What impact do ARK's trades have on the companies involved?

How does ARKK's current performance compare to its competitors?

What are the potential long-term effects of ARKK's recent investment shifts?

What challenges does ARKK face in maintaining its portfolio strategy?

How does ARK's focus on innovation distinguish it from traditional ETFs?

What controversies surround ARKK's investment choices?

What feedback do investors typically provide about ARKK's performance?

How could changes in regulatory policies impact ARK's investment strategy?

What historical performance data can provide context for ARKK's current strategies?

What future technologies might influence ARK's investment focus?

How do ARK's investment trends correlate with market volatility?

Search
NextFinNextFin
NextFin.Al
No Noise, only Signal.
Open App